MITF表达对黑色素瘤透瘤淋巴细胞的影响:洞察免疫微环境动态
Damir Vučinić1, Matea Lekić2, Gordana Žauhar3
1Tumor Clinic, Clinical Hospital Centre Rijeka, Rijeka, Croatia; Department of Oncology and Radiotherapy, University of Rijeka, Faculty of Medicine, Rijeka, Croatia.
Biomolecules & biomedicine
|February 20, 2025
概括
微相关转录因子 (MITF) 表达与黑色素瘤中的免疫细胞透有关. 在特定的瘤透淋巴细胞 (TIL) 模式和B细胞存在的情况下观察到更高的MITF水平,这表明免疫微环境相互作用影响黑色素瘤的进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 黑色素瘤的进展涉及复杂的瘤细胞和免疫微环境的相互作用.
- 了解这些相互作用对于开发有效的黑色素瘤疗法至关重要.
研究的目的:
- 为了研究微相关转录因子 (MITF) 表达和原发性黑色素瘤中的免疫微环境之间的关系.
- 为了评估瘤透淋巴细胞 (TILs) 的修改分类,与MITF水平相关.
主要方法:
- 分析81个原发性黑色素瘤组织样本,使用组织微阵列免疫组织化学检测MITF蛋白水平.
- 将TIL模式分为六组,对透类型和分布的BRISK分类进行细化.
- 包括克鲁斯卡尔-瓦利斯试验在内的统计分析,以评估TIL组之间的MITF表达的差异和与CD20+B淋巴细胞的相关性.
主要成果:
- 具有BRISK B类型TILs的黑色素瘤显示MITF表达率最高 (>50%).
- 非和缺席TIL组显著降低了MITF表达 (分别为32.73%和22.00%).
- CD20+B淋巴细胞的存在与增加的MITF表达相关 (P=0.009). MITF基因放大显示了蛋白质表达的趋势 (P=0.058).
结论:
- 精细的TIL分类为黑色素瘤免疫生物学提供了更深入的见解.
- MITF表达与特定的TIL模式和B细胞透显著相关.
- 这些发现可能有助于预测患者对免疫治疗的反应.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
7.1K
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463